Incyte Canada Announces Health Canada approval of Opzelura® (Ruxolitinib) Cream for the Treatment of Atopic Dermatitis in Children Ages 2-11

Incyte Biosciences Canada today announced that Health Canada has approved Opzelura® (ruxolitinib (as ruxolitinib phosphate)) ...

Ericsson and Export Development Canada advance Canada's leadership in next-generation networks with $3 billion USD partnership agreement

Ericsson today announced the signing of a USD $3 billion partnership agreement with Export Development Canada (EDC) to expand investment in Canadian research and development, deepen domestic supply ...
Business Insider

How to watch Survivor: Live stream Season 49 free from anywhere

Every time Adam publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from Business ...